| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,338 |
5,714 |
$421K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,159 |
10,522 |
$403K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,293 |
3,781 |
$228K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,990 |
2,686 |
$145K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
464 |
412 |
$99K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,111 |
1,783 |
$96K |
| 99460 |
|
689 |
597 |
$58K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,329 |
1,130 |
$55K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,114 |
948 |
$53K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
268 |
251 |
$29K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
519 |
473 |
$25K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
288 |
246 |
$12K |
| 99215 |
Prolong outpt/office vis |
96 |
90 |
$11K |
| 90697 |
|
641 |
618 |
$9K |
| 54150 |
|
50 |
49 |
$9K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
580 |
534 |
$9K |
| 83655 |
|
531 |
445 |
$7K |
| 90680 |
|
541 |
522 |
$7K |
| 90677 |
|
485 |
455 |
$6K |
| 96127 |
|
2,637 |
2,180 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
314 |
284 |
$4K |
| 90671 |
|
265 |
262 |
$3K |
| 90686 |
|
257 |
220 |
$3K |
| 90656 |
|
183 |
176 |
$3K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,346 |
1,091 |
$2K |
| 87634 |
|
27 |
27 |
$2K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
562 |
508 |
$2K |
| 90633 |
|
168 |
158 |
$2K |
| 90716 |
|
144 |
139 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
134 |
120 |
$2K |
| 81002 |
|
309 |
264 |
$957.59 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
15 |
13 |
$953.18 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
31 |
28 |
$758.19 |
| 99383 |
|
13 |
12 |
$671.11 |
| 85018 |
|
237 |
207 |
$614.75 |
| 90651 |
|
31 |
24 |
$602.53 |
| 90707 |
|
43 |
40 |
$459.90 |
| 90619 |
|
12 |
12 |
$372.78 |
| 90381 |
|
17 |
17 |
$223.38 |
| 88738 |
|
34 |
28 |
$206.11 |
| 94760 |
|
12 |
12 |
$114.40 |
| 99489 |
Ccm add 20min |
349 |
330 |
$0.00 |
| 96161 |
|
696 |
587 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
17 |
13 |
$0.00 |
| 96160 |
|
69 |
59 |
$0.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
150 |
117 |
$0.00 |